No additional AEs were reported; Pharmacist reported that a patient received first dose of GARDASIL 9 about 5 years ago and second dose on 1/14/2025; This spontaneous report was received from a pharmacist, concerning a patient of unknown age and gender. The patient’s medical history, concurrent conditions, historical drugs, and concomitant therapies were not reported. On an unknown date in 2020 (reported as “about 5 years ago”), the patient was vaccinated with the 1st dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection. On 14-JAN-2025, the patient received the 2nd dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (Inappropriate schedule of product administration). Both doses were administered as prophylaxis and exact dosage, lot numbers, expiration dates, routes of administration, and anatomical locations were not provided. No additional adverse events (AEs) were reported and no further information was provided. Lot # is being requested and will be submitted if received.